Terms: = Breast cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Treatment
145 results:
1. DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT.
Shen M; Cao S; Long X; Xiao L; Yang L; Zhang P; Li L; Chen F; Lei T; Gao H; Ye F; Bu H
Redox Biol; 2024 Apr; 70():103035. PubMed ID: 38306757
[TBL] [Abstract] [Full Text] [Related]
2. PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression.
Peng ZM; Han XJ; Wang T; Li JJ; Yang CX; Tou FF; Zhang Z
Breast Cancer Res; 2024 Jan; 26(1):10. PubMed ID: 38217030
[TBL] [Abstract] [Full Text] [Related]
3. Protein disulfide isomerase family member 4 promotes triple-negative breast cancer tumorigenesis and radiotherapy resistance through JNK pathway.
Tao J; Xue C; Cao M; Ye J; Sun Y; Chen H; Guan Y; Zhang W; Zhang W; Yao Y
Breast Cancer Res; 2024 Jan; 26(1):1. PubMed ID: 38167446
[TBL] [Abstract] [Full Text] [Related]
4. Estrogen receptor beta suppresses the androgen receptor oncogenic effects in triple-negative breast cancer.
Xu F; Xu K; Fan L; Li X; Liu Y; Yang F; Zhu C; Guan X
Chin Med J (Engl); 2024 Feb; 137(3):338-349. PubMed ID: 38105538
[TBL] [Abstract] [Full Text] [Related]
5. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer.
Chan SH; Kuo WH; Wang LH
J Biomed Sci; 2023 Nov; 30(1):93. PubMed ID: 38037106
[TBL] [Abstract] [Full Text] [Related]
6. NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of EGFR signaling.
Qiao L; Dong C; Jia W; Ma B
Cell Signal; 2023 Dec; 112():110922. PubMed ID: 37827343
[TBL] [Abstract] [Full Text] [Related]
7. Impact of the COVID-19 pandemic on women living with and beyond breast cancer: a qualitative study of women's experiences and how they varied by social determinants of health.
Myers C; Waldron C; Bennett K; Cahir C
BMC Cancer; 2023 Sep; 23(1):867. PubMed ID: 37715181
[TBL] [Abstract] [Full Text] [Related]
8. A novel RBBP8(p.E281*) germline mutation is a predisposing mutation in familial hereditary cancer syndrome.
Yan J; Wu J; Wang Y; Di X; Jiang H; Wen D; Li D; Zhang S
J Mol Med (Berl); 2023 Oct; 101(10):1255-1265. PubMed ID: 37615686
[TBL] [Abstract] [Full Text] [Related]
9. Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte.
Chen Z; Li R; Fang M; Wang Y; Bi A; Yang L; Song T; Li Y; Li Q; Lin B; Jia Y; Fu S; Fu S; Xiong H
Int J Med Sci; 2023; 20(8):1060-1078. PubMed ID: 37484811
[No Abstract] [Full Text] [Related]
10. Curcumin targets miR-134-5p to suppress the progression of colorectal cancer through regulating the CDCA3/CDK1 pathway.
Liu F; Zhu C; Ma H; Yang Q
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):109-122. PubMed ID: 37368030
[TBL] [Abstract] [Full Text] [Related]
11. DYNLT1 promotes mitochondrial metabolism to fuel breast cancer development by inhibiting ubiquitination degradation of VDAC1.
Huang L; Wei B; Zhao Y; Gong X; Chen L
Mol Med; 2023 Jun; 29(1):72. PubMed ID: 37280526
[TBL] [Abstract] [Full Text] [Related]
12. Identifying cultural, demographic, personal health and cancer-related barriers to integrative oncology care: a retrospective case-cohort study.
Samuels N; Cohen N; Katz D; Ben-Arye E
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10143-10148. PubMed ID: 37264264
[TBL] [Abstract] [Full Text] [Related]
13. CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.
Lin Y; Zhao Y; Chen M; Li Z; Liu Q; Chen J; Ding Y; Ding C; Ding Y; Qi C; Zheng L; Li J; Zhang R; Zhou J; Wang L; Zhang QQ
BMC Cancer; 2023 May; 23(1):479. PubMed ID: 37237269
[TBL] [Abstract] [Full Text] [Related]
14. Longitudinal trajectories of illness perception regarding breast cancer-related lymphedema among women with breast cancer.
Chen J; Guo Z; Luo X; Zhang Y; Zhang X; Li M; Xiong C; Zhao M; Yan J
J Psychosom Res; 2023 Jul; 170():111344. PubMed ID: 37178472
[TBL] [Abstract] [Full Text] [Related]
15. Fibroblast Activation Protein-Targeted Radioligand Therapy for treatment of Solid Tumors.
Lindeman SD; Mukkamala R; Horner A; Tudi P; Booth OC; Huff R; Hinsey J; Hovstadius A; Martone P; Zhang F; Srinivasarao M; Cox A; Low PS
J Nucl Med; 2023 May; 64(5):759-766. PubMed ID: 37116911
[TBL] [Abstract] [Full Text] [Related]
16. CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop.
Zheng W; Wang X; Yu Y; Ji C; Fang L
Cell Mol Biol Lett; 2023 Apr; 28(1):34. PubMed ID: 37101128
[TBL] [Abstract] [Full Text] [Related]
17. Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases.
Yang A; Zhang Z; Chaurasiya S; Park AK; Jung A; Lu J; Kim SI; Priceman S; Fong Y; Woo Y
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37019471
[TBL] [Abstract] [Full Text] [Related]
18. PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis.
Liu A; Yu C; Qiu C; Wu Q; Huang C; Li X; She X; Wan K; Liu L; Li M; Wang Z; Chen Y; Hu F; Song D; Li K; Zhao C; Deng H; Sun X; Xu F; Lai S; Luo X; Hu J; Wang G
Oncogene; 2023 May; 42(19):1572-1584. PubMed ID: 36991117
[TBL] [Abstract] [Full Text] [Related]
19. PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer.
Gao S; Zhang W; Ma J; Ni X
J Transl Med; 2023 Mar; 21(1):220. PubMed ID: 36967443
[TBL] [Abstract] [Full Text] [Related]
20. The Impact of Social Determinants of Health on the Time Between Diagnostic breast Imaging and Biopsy at a Safety Net Hospital.
Dao K; Afran A; LeBedis C; Fishman MDC
J Am Coll Radiol; 2023 Apr; 20(4):393-401. PubMed ID: 36682645
[TBL] [Abstract] [Full Text] [Related]
[Next]
